KM195 as an immunohistochemical marker of adenocarcinoma of the lung

Lung Cancer

Volumn 15, Issue 1, 1996, Pages 41-50

  Kawai, Toshiaki ^a   Hiroi, Sadayuki ^a   Hanai, Nobuo ^b   Shitara, Kenya ^b  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

Adenocarcinoma; Immunohistochemistry; Lung carcinoma; Monoclonal antibody; Western blotting

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CAM 5.2; MONOCLONAL ANTIBODY KM 195; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG CARCINOMA; LUNG METASTASIS; LUNG SMALL CELL CANCER; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

EID: 0030221313     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/0169-5002(96)00569-7     Document Type: Article

References (23)

1. [1] The Japanese Society of Pathology. Annals of Pathological Autopsy Records in Japan (1974 1983). Tokyo: The Japanese Society of Pathology.
2. [2] Aoki K, Oono Y. Epidemiology of lung cancer and etiological consideration. Nihon-Rinsho 1980; 38: 2541-2550.
3. [3] Banks-Schlegel SP, McDowell EM, Wilson TS, Trump BF, Harris CC. Keratin proteins in human lung carcinomas. Combined use of morphology, keratin immunocytochemistry, and keratin immunoprecipitation. Am J Pathol 1984; 1114: 273-286.
4. [4] Battifora H, Kopinski M. The influence of protease digestion and duration of fixation on the immunostaining of keratins. A comparison of formalin and ethanol fixation. J Histochem Cytochem 1986; 34: 1095-1100.
5. [5] Broers JV, Ramaekers FS, Rot MK, Oostendrop T, Huysmans A, Muijen GNP, Wagenaar SS, Vooijis GP. Cytokeratins in different types of human lung cancer as monitored by chain-specific monoclonal antibodies. Cancer Res 1988; 48: 3221-3229.
6. [6] Chan R, Edwards BF, Hu R, Rossitt PV, Min BH, Lund JK, Cardiff RD. Characterization of two monoclonal antibodies in an immunohistochemical study of keratin 8 and 18 expression. Am J Clin Pathol 1988; 89: 472-480.
7. [7] Cooper D, Schermer A, Sun T-T. Classification of human epithelia and their neoplasms using monoclonal antibodies to keratins: strategies, applications, and limitations. Lab Invest 1985; 52: 243-256.
8. [8] Dale I, Brandtzaeg P. Expression of the epithelial L1 antigen as an immunohistochemical marker of squamous cell carcinoma of the lung. Histopathology 1989; 4: 493-502.
9. [9] Elias JM, Margiotta M, Gabore D. Sensitivity and detection efficiency of the peroxidase antiperoxidase (PAP), avidin-biotin peroxidase complex (ABC), and peroxidase-labeled avidin-biotin (LAB) methods. Am J Clin Pathol 1989; 92: 62-67.
10. [10] J Health Welfare Stat 1994; 41(1): 25-31.
11. [11] Kawai T, Suzuki M, Kase K, Ozeki Y. Expression of carbohydrate antigens in human pulmonary adenocarcinoma. Cancer 1993; 72: 1581-1587.
12. [12] Kawai T, Suzuki M. Histochemical and biochemical aspects of lectin binding glycoproteins in primary and metastatic adenocarcinoma in the lung. Mod Pathol 1994; 7(2): 175-180.
13. [13] Linnoila RI, Jensen SM, Steinberg SM, Mulshine JL, Eggleston JC, Gazdar AF. Peripheral airway cell marker expression in non-small cell lung carcinoma. Am J Clin Pathol 1992; 97: 233-243.
14. [14] Mayall FG, Gibbs AR. An assessment of MAC 387 antibody as a diagnostically useful marker of L1 epithelial antigen expression by lung tumours. J Pathol 1991; 164: 47-50.
15. [15] Miyake M, Zenita K, Tanaka O, Okada Y, Kannagi R. Stage-specific expression of SSEA-1-related antigens in the developing lung of human embryos and its relation to the distribution of these antigens in lung cancers. Cancer Res 1988; 48: 7150-7158.
16. [16] Mizutani Y, Nakajima T, Morinaga S, Gotoh M, Shimosato Y, Akino T, Suzuki A. Immunohistochemical localization of pulmonary surfactant apoproteins in various lung tumors. Cancer 1988; 61: 532-537.
17. [17] Moll R, Löwe A, Laufer J, Franke WW. Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol 1992; 140: 427-447.
18. [18] Shitara K, Fugiwara K, Kusano A, Yamaguchi K, Yoshida H, Sato S, Hanai N. Application of anti lung adenocarcinoma monoclonal antibody recognizing cytokeratin-like cytoplasmic antigen for tumor diagnosis. Anticancer Res 1992; 12: 1121-1130.
19. [19] Suehiro T, Maeda K, Sueishi K. Immunohistochemical study of lung adenocarcinoma using monoclonal antibody for 60-kilodalton antigen in Type II pneumocytes and nonciliated bronchiolar epithelial cells. Am J Clin Pathol 1989; 92: 150-158.
20. [20] Sugiyama K, Kawai T, Nagata N, Suzuki M. Tumor-associated carbohydrate antigens in primary adenocarcinomas and their metastases. Hum Pathol 1992; 23: 900-904.
21. [21] Watanabe S, Tsugane S, Arimoto H, Shimosato Y, Suemasu K, Arai H. Urano Y. Trend of lung cancers in the National Cancer Center of Japan and comparison with that of Japanese Pathological Autopsy Records. Jpn J Cancer Res (Gann) 1987; 78: 460-466.
22. [22] World Health Organization. Histological Typing of Lung Tumours, Vol. 1, 2nd edn., International Histological Classification of Tumours No. 1. Geneva: WHO, 1981.
23. [23] Yoshimura K, Yamashita N, Ishikawa H. Clinical aspects of lung cancer by histologic subtypes in Japan. Nihon-Rinsho 1980; 38: 2581-2591.